In this latter study, anti-SOX13 was detected in 18% of patients with PBC, 13% with autoimmune hepatitis, and 18% with type 1 diabetes, at lower frequencies in other conditions including the multisystem autoimmune diseases, SLE, and rheumatoid arthritis, but in only 1% of normal sera. Here, SOX13 is linked to type 1 diabetes mellitus.